[Value of S100A8 in evaluating the prognosis of children with acute lymphoblastic leukemia]

Mei-Fei Ouyang1, Dan Wang, Ying-Ting Liu

  • 1Department of Pediatrics, Xiangya Hospital, Central South University, Changsha 410008, China. yamahua123@163.com.

Insights

High S100A8 expression is linked to poor prognosis in pediatric acute lymphoblastic leukemia (ALL). This finding suggests S100A8 may serve as a biomarker for personalized ALL treatment strategies.

Area of Science:

  • Pediatric Oncology
  • Molecular Diagnostics
  • Biomarker Discovery

Background:

  • Acute lymphoblastic leukemia (ALL) is the most common childhood cancer.
  • Identifying reliable prognostic markers is crucial for effective treatment strategies in pediatric ALL.
  • S100A8, a calcium-binding protein, has been implicated in various inflammatory and neoplastic processes.

Purpose of the Study:

  • To investigate the association between S100A8 expression levels and treatment outcomes in children diagnosed with ALL.
  • To evaluate the potential of S100A8 as a prognostic biomarker in pediatric ALL.

Main Methods:

  • Retrospective analysis of clinical data from 377 children with ALL treated with the CCLG-2008-ALL regimen.
  • Quantification of serum S100A8 protein and mRNA levels using ELISA and PCR, respectively.
  • Survival analysis utilizing Kaplan-Meier curves and Cox regression modeling.

Main Results:

  • Overall survival rate was 89.1% in the cohort.
  • Lower S100A8 protein and mRNA levels were observed in patients with a good prednisone response.
  • Elevated S100A8 levels correlated with poorer event-free survival and were associated with different risk stratifications.
  • S100A8 overexpression emerged as an independent risk factor for adverse prognosis in pediatric ALL.

Conclusions:

  • High S100A8 expression is associated with unfavorable prognosis in children with ALL.
  • S100A8 shows promise as a novel biomarker for guiding individualized precision therapy in pediatric ALL patients.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.1K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
936
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
487